Institution: | 1. Medicinal Chemistry Laboratories, Taisho Pharmaceutical Co., Ltd., 1–403 Yoshino-cho, Kita-ku, Saitama 331–9530, Japan;2. Discovery Technologies Laboratories, Taisho Pharmaceutical Co., Ltd., 1–403 Yoshino-cho, Kita-ku, Saitama 331–9530, Japan;3. Pharmacology Laboratories, Taisho Pharmaceutical Co., Ltd., 1–403 Yoshino-cho, Kita-ku, Saitama 331–9530, Japan;1. Cancer Drug Research Laboratory, Department of Medicine, Division of Medical Oncology, McGill University Health Center/Glen Hospital, 1001 Decarie Blvd, Montreal H4A 3J1, Quebec, Canada;2. Chemical Computing Group Inc., 1010 Sherbrooke Street West, Suite 910, Montreal H3A 2R7, Quebec, Canada;1. New Drug Research & Development Center, North China Pharmaceutical Group Corporation, Shijiazhuang 050015, Hebei, China;2. National Microbial Medicine Engineering & Research Center, Shijiazhuang 050015, Hebei, China;3. Hebei Industry Microbial Metabolic Engineering & Technology Research Center, Shijiazhuang 050015, Hebei, China;4. Key Laboratory for New Drug Screening Technology of Shijiazhuang City, Shijiazhuang 050015, Hebei, China;1. College of Chemistry and Chemical Engineering, Central South University, Changsha, Hunan 410083, PR China;2. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, PR China;3. Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, PR China;4. Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, PR China |